Taylor Wessing acted for Protembis GmbH on the series B Financing Round led by Tech Vision Fonds, Segulah Medical Acceleration, XGEN Venture and Gehrenberg advised by...
Protembis GmbH’s €30 Million Series B Financing Round
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...